EP3658141
Meðhöndlun sjúkdómsástands með beinni og óbeinni miðun á SIRPalfa - CD47 víxlverkun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.7.2018EP published:
16.11.2022EP application number:
18770099.2
EP translation filed:
8.2.2023Grant published:
15.3.2023EPO information:
European Patent Register
Max expiry date:
23.7.2038Expiry date:
23.7.2026Next due date:
31.7.2026
Title in English:
TREATING PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPALPHA - CD47 INTERACTIONLanguage of the patent:
English
Timeline
Today
24.7.2018EP application
16.11.2022EP Publication
8.2.2023Translation submitted
15.3.2023Registration published
23.7.2026Expires
Owner
Name:
Scenic Immunology B.V.Address:
Matrix ONE Science Park 301, 1098 XH Amsterdam, NL
Inventor
Name:
RAABEN, MatthijsAddress:
1191 PN Ouderkerk aan de Amstel, NL
Name:
SCHEEREN, Ferenc AlexanderAddress:
NL-2333 ZA Leiden, NL
Name:
LOGTENBERG, Meike Emma WillemijnAddress:
1066 CX Amsterdam, NL
Name:
BRUMMELKAMP, Thijn ReinoutAddress:
1066 CX Amsterdam, NL
Name:
SCHUMACHER, Antonius Nicolaas MariaAddress:
1066 CX Amsterdam, NL
Name:
LEUSEN, Jeannette Henrica WilhelminaAddress:
3515 VV Utrecht, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2019333Date:
24.7.2017Country:
NL
Number:
2020938Date:
15.5.2018Country:
NL
Classification
Categories:
A61K 31/417, A61K 39/00, A61K 45/00, A61P 31/00, A61P 9/10, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.7.2023
Expires: 23.7.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 13.6.2024
Expires: 23.7.2025
Payer: NOVEMBER FIRST A/S
Number: 8
Paid: 14.7.2025
Expires: 23.7.2026
Payer: Patent Renewal ApS